Very proud of my team for the management of this complex case and to the residents who won first place in the poster competition at Ohio ACC. Steven Yakubov⁩ ⁦Carlos E. Sanchez MD⁩ jacc.org/doi/10.1016/S0…

Here’s a look at our poster for those who would like to take a closer look! SGIM #SGIM23 #MedTwitter #MedEd #FOAMed

Chatting about PCP integration in post-COVID care with Kathy Wu at #SGIM23 ☺️

Presenting about tobacco cessation 🚭#QI #MedEd at #SGIM23 SGIM today. Riverside IM Residency (OhioHealth) Mariah Barlow

Excited to see this project in print!!🫀 Thank you to European Society of Cardiology and EHJCaseReports Editor-in-Chief editors and reviewers ✍️ Loved collaborating with Riverside IM Residency (OhioHealth) co-residents, attendings, and med students on this.

Happy to be in Honolulu, Hawaii talking intercostal lung herniation at #CHEST2023 Riverside IM Residency (OhioHealth)

Honored to present my work in tobacco cessation #QI #MedEd at #CHEST2023! 🚭 Mariah Barlow Riverside IM Residency (OhioHealth)

On Internal Medicine Day, congratulations to the 2024 Alliance Awards recipients! We are grateful for your valuable input and dedication to our community. ow.ly/ZOEa50Q1HBT #InternalMedicineDay #IMPhysician #IMProud

#MedTwitter - Plan your week with us! We have an exciting week ahead here at Clinical Problem Solvers. Join our live sessions using the link➡️ bit.ly/31LWIKg

Excited to 👀 the virtual #MedTwitter #Match2024 The Clinical Problem Solvers community on Saturday! cc: Aimee Willett Christopher Wasco Aditya Kesari Ellen C. Tan, D.O. Sanjay A. Patel, MD (he/him/his)

Had fun collaborating with good friend and recent Riverside IM Residency (OhioHealth) grad Dr. Graef on this write up! Interesting case presentation and loved being part of this multidisciplinary team with path and heme experts from RMH and neighboring OSU! 🩸🦠

🎤 hypertrophic cardiomyopathy left ventricular non compaction overlap phenotype at #ACC24 Thank you Katie & Akira Wada for your mentorship on this report!

Takeaways from #ACC2024. Late breaking trials - take home points American College of Cardiology 1. RELIEVE-HF Trial: In patients with HFrEF and HFpEF, Interatrial Shunt did not show any significant difference in the primary effectiveness endpoint, a composite of all-cause mortality, LVAD/heart

Excited to learn with this great group Riverside IM Residency (OhioHealth) Aimee Willett #AIMW24 AAIM Someone cut your head off Mariah Barlow 😬